Patent World Magazine

Biotechnology patent progress

Kathryn Robinson of Hempsons considers the most recent UK and EPO developments in stem cell and gene patenting

Article 6.1 of the Biotechnology Directive states, “Inventions shall be considered unpatentable where their commercial exploitation would be contrary to ordre public [meaning public policy] or morality; however, exploitation shall not be deemed to be so contrary merely because it is prohibited by law or regulation.” Article 6.2 of the Biotechnology Directive goes on to list, in a non-exhaustive way, what is considered unpatentable on these grounds:

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, click Log In button.

Copyright © 2024 Maritime Insights & Intelligence Limited. Maritime Insights & Intelligence Limited is registered in England and Wales with company number 13831625 and address 5th Floor, 10 St Bride Street, London, EC4A 4AD, United Kingdom. Lloyd's List Intelligence is a trading name of Maritime Insights & Intelligence Limited.

Lloyd's is the registered trademark of the Society Incorporated by the Lloyd's Act 1871 by the name of Lloyd's.